@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_head { this: np:hasAssertion dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_assertion; np:hasProvenance dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_provenance; np:hasPublicationInfo dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_publicationInfo; a np:Nanopublication . dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_assertion a np:Assertion . dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_provenance a np:Provenance . dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_publicationInfo a np:PublicationInfo . } dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_assertion { miriam-gene:4846 a ncit:C16612 . lld:C0022116 a ncit:C7057 . dgn-gda:DGNc1ea4b6b4b84a77da87ed1e9ca3d7e12 sio:SIO_000628 miriam-gene:4846, lld:C0022116; a sio:SIO_001121 . } dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_provenance { dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_assertion dcterms:description "[Compared with the vehicle-treated I/R, EPO improved tissue injury; decreased the intensity of eNOS immunolabelling (1.6+/-0.24 vs 3+/-0.4, P<0.05), the number of TUNEL-positive cells (9.2+/-2.7 vs 20.4+/-2.6, P<0.01), and the high histological scores (1+/-0.51 vs 3+/-0.36, P<0.01), and increased catalase activity (42.85+/-6 vs 16.83+/-2.6, P<0.01) when given before ischemia, while it was found to have decreased the levels of MDA (0.483+/-0.025 vs 0.747+/-0.076, P<0.05) and MPO activity (3.86+/-0.76 vs 10.51+/-1.87, P<0.05), intensity of eNOS immunolabelling (1.4+/-0.24 vs 3+/-0.4, P<0.01), the number of TUNEL-positive cells (9.1+/-3 vs 20.4+/-2.6, P<0.01), and the number of high histological scores (1.16+/-0.4 vs 3+/-0.36, P<0.05) when given at the onset of reperfusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:17873970; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP197322.RARYGxNgy_2OlWXpuL1b9D6SzLcyNvHv2aEvxXeUcdxi0130_publicationInfo { this: dcterms:created "2014-10-02T12:33:48+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }